Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010

Alzheimer's and Dementia

Volumn 7, Issue 2, 2011, Pages 127-132

  Khachaturian, Zaven S ^a   Petersen, Ronald C ^b   Snyder, Peter J ^c   Khachaturian, Ara S ^a   Aisen, Paul ^d   De Leon, Mony ^e   Greenberg, Barry D ^f   Kukull, Walter ^g   Maruff, Paul ^h   Sperling, Reisa A ⁱ   Stern, Yaakov ^j   Touchon, Jacques ^k   Vellas, Bruno ^l   Andrieu, Sandrine ^m   Weiner, Michael W ⁿ   Carrillo, Maria C ^o   Bain, Lisa J ^a  

^a Campaign to Prevent Alzheimer's Disease by 2020 ^*  (United States)

^b MAYO CLINIC   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^f Toronto Dementia Research Alliance   (Canada)

^g UNIVERSITY OF WASHINGTON   (United States)

^h CogState ^*  (Australia)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^k GUI DE CHAULIAC HOSPITAL   (France)

^l TOULOUSE UNIVERSITY HOSPITAL   (France)

^m Acute Unit for Alzheimer's Patients   (France)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o ALZHEIMER'S ASSOCIATION   (United States)

more..

Author keywords

Alzheimer's disease; Biomarkers; Computational biology; Computerized cognitive assessment; Dementia; Genetics; Healthy aging; In silico modeling; Longitudinal study; Mild cognitive impairment; Presymptomatic Alzheimer's disease; Prevention; Registry

Indexed keywords

AGING; ALZHEIMER DISEASE; BEHAVIOR CHANGE; COMPUTER MODEL; CONFERENCE PAPER; DATA ANALYSIS; DATA MINING; DEMENTIA; DISEASE REGISTRY; EARLY DIAGNOSIS; HUMAN; LONGITUDINAL STUDY; MATHEMATICAL MODEL; MEMORY; PREVENTION STUDY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT;

ALZHEIMER DISEASE; CONGRESSES AS TOPIC; HUMANS; PREVENTIVE MEDICINE; REGISTRIES; WORLD HEALTH;

EID: 79952718052     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.02.005     Document Type: Conference Paper

References (11)

1. Khachaturian ZS, Camí J, Andrieu S, Avila J, Boada Rovira M, Breteler M, Froelich L, et al. Creating a transatlantic research enterprise for preventing Alzheimer's disease. Alzheimers Dement 2009;5:361-6.
2. Khachaturian AS, Chapman J, Farrer L, Friedland RP, Ebstein R, Grossman I, et al. Healthy aging and preclinical dementia: the United States-Israel Longitudinal Database Project. Alzheimers Dement 2010;6:475-81.
3. Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, et al. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. Alzheimers Dement 2008;4:96-109. (Pubitemid 351373200)
4. Trojanowski JQ, Arnold SE, Karlawish JH, Brunden K, Cary M, Davatzikos C, et al. Design of comprehensive Alzheimer's disease centers to address unmet national needs. Alzheimers Dement 2010;6:150-5.
5. Snyder PJ, Papp KV, Bartkowiak J, Jackson CE, Doody RS. Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities and industry sponsors. Alzheimers Dement 2009;5:122-4.
6. Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, de Leon MJ. Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis 2010;20:843-54.
7. Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, et al. Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol Aging 2009;30:682-90.
8. De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol 2010;67:949-56.
9. de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, et al. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann N YAcad Sci 2007;1097:114-45. (Pubitemid 47084889)
10. Jun G, Naj AC, Beecham GW, Wang L-S, Buros J, Gallins PJ, et al. Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 2010;67:1473-84.
11. Roses AD. An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease. Arch Neurol 2010;67:536-41.